Skip to main content
    R

    Regencell Bioscience Holdings Ltd (RGC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $4.72
    -0.22 (-4.45%)

    Market Cap: $2.45B

    Last updated: Nov 17, 2026 at 4:38 PM ET

    Regencell Bioscience Holdings Ltd (RGC) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Regencell Bioscience Holdings (RGC) has a latest price of $4.72 on Nov 17, 2026, 93.2% below its 52-week high of $69.00. Its price fell 63.7% over the past 12 months. The month-end price rose 1,798.7% over the 5 years through Oct 2026, a compound annual rate of 80.2%.

    Price Chart

    From Jul 2021 to Oct 2026, its highest month-end close was $29.22 in Apr 2026 and its lowest $0.09 in Jun 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart RGC with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RGC.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 13.6%, and over 6 months it fell 83.0%. The month-end price rose 1,500.3% over the 3 years through Oct 2026, a compound annual rate of 152.0%.

    PeriodChange
    1 month-50.8%
    3 months-13.6%
    6 months-83.0%
    12 months-63.7%
    12 months, with dividends-63.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+1,500.3%+152.0%
    5 years+1,798.7%+80.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 16,053.8%, and its weakest was 2023, when it fell 62.4%.

    YearCloseChange
    2026 through Oct 2026$6.71-68.0%
    2025$21.00+16,053.8%
    2024$0.13-52.9%
    2023$0.28-62.4%
    2022$0.73-12.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 30.1% below its 50-day average of $6.75 and 70.3% below its 200-day average of $15.88.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$4.72
    52-week high$69.00-93.2%
    52-week low$4.51+4.7%
    50-day average$6.75-30.1%
    200-day average$15.88-70.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 94.0%.

    MeasureValue
    1-year beta1.35
    Largest fall, 1 year-91.1%
    Largest fall, 3 years-94.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About RGC

    What is RGC's 1-year price change?

    Regencell Bioscience Holdings's price fell 63.7% over the past 12 months. With dividends included, the 12-month total return was -63.7%.

    What is RGC's 5-year price change?

    Regencell Bioscience Holdings's month-end price rose 1,798.7% over the 5 years through Oct 2026, a compound annual rate of 80.2%. These figures leave out dividends.

    What is RGC's 52-week high and low?

    Regencell Bioscience Holdings's 52-week high is $69.00 and its 52-week low is $4.51. Its latest price of $4.72 on Nov 17, 2026 is 93.2% below the high.

    What is RGC's beta?

    Regencell Bioscience Holdings's 1-year beta against the S&P 500 is 1.35, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 91.1%.

    Is the RGC chart free?

    Yes. Advanced Charting for RGC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.